The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

TRUSOPT 20 mg/ml eye drops, solution

Santen OYPA0879/004/001

Main Information

Trade NameTRUSOPT 20 mg/ml eye drops, solution
Active SubstancesDorzolamide hydrochloride
Dosage FormEye drops, solution
Licence HolderSanten OY
Licence NumberPA0879/004/001

Group Information

ATC CodeS01EC03 dorzolamide


License statusAuthorised
Licence Issued20/04/1995
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back